A number of materials can crystallize in forms known as polymorphs, with these forms differing in the crystal lattice’s three-dimensional arrangement of molecules or atoms. Polymorphs tend to possess ...
Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; "Rigaku"), announced ...
MADISON, Wis.--(BUSINESS WIRE)--Breakthrough research has now revealed the true crystal forms of pharmaceutical psilocybin. A new study overcomes experimental challenges to solve the crystallographic ...
Crystal polymorphism is critically important in the fields of pharmaceuticals and materials science. For instance, a metastable polymorph of an active pharmaceutical ingredient may benefit from ...
MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...
We were so pleased to have the opportunity to address InformaMarkets’ 13 th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents. Patents covering one or more crystalline ...
Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country Patenting polymorphs of crystalline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results